SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chen-Yan Zhao, Zheng Jiao, Jun-Jun Mao, Xiao-Yan Qiu, External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients, British Journal of Clinical Pharmacology, 2016, 81, 5
  2. 2
    Mélanie Wilbaux, Aline Fuchs, Janko Samardzic, Frédérique Rodieux, Chantal Csajka, Karel Allegaert, Johannes N. Anker, Marc Pfister, Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates, The Journal of Clinical Pharmacology, 2016, 56, 5
  3. 3
    Janko Samardzic, Karel Allegaert, Mélanie Wilbaux, Marc Pfister, John N. van den Anker, Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period, Expert Opinion on Drug Metabolism & Toxicology, 2016, 12, 4, 367

    CrossRef

  4. You have free access to this content4
    Jiraganya Bhongsatiern, Chris Stockmann, Tian Yu, Jonathan E. Constance, Ganesh Moorthy, Michael G. Spigarelli, Pankaj B. Desai, Catherine M. T. Sherwin, Renal Function Descriptors in Neonates: Which Creatinine-Based Formula Best Describes Vancomycin Clearance?, The Journal of Clinical Pharmacology, 2016, 56, 5
  5. 5
    Steven Pauwels, Karel Allegaert, Therapeutic drug monitoring in neonates, Archives of Disease in Childhood, 2016, 101, 4, 377

    CrossRef

  6. 6
    Nguessan Aimé Brou, Evelyne Jacqz-Aigrain, Wei Zhao, Cystatin C as a potential biomarker for dosing of renally excreted drugs, British Journal of Clinical Pharmacology, 2015, 80, 1
  7. 7
    Evelyne Jacqz-Aigrain, Stephanie Leroux, Wei Zhao, John N van den Anker, Mike Sharland, How to use vancomycin optimally in neonates: remaining questions, Expert Review of Clinical Pharmacology, 2015, 8, 5, 635

    CrossRef

  8. 8
    Janko Samardzic, Mark A Turner, Ralph Bax, Karel Allegaert, Neonatal medicines research: challenges and opportunities, Expert Opinion on Drug Metabolism & Toxicology, 2015, 11, 7, 1041

    CrossRef

  9. 9
    Matthijs Oyaert, Nele Peersman, Davy Kieffer, Kathleen Deiteren, Anne Smits, Karel Allegaert, Isabel Spriet, Johan Van Eldere, Jan Verhaegen, Pieter Vermeersch, Steven Pauwels, Novel LC–MS/MS method for plasma vancomycin: Comparison with immunoassays and clinical impact, Clinica Chimica Acta, 2015, 441, 63

    CrossRef

  10. 10
    Wei Zhao, Stéphanie Leroux, Evelyne Jacqz-Aigrain, Dosage individualization in children: integration of pharmacometrics in clinical practice, World Journal of Pediatrics, 2014, 10, 3, 197

    CrossRef

  11. 11
    Jessica K. Roberts, Chris Stockmann, Jonathan E. Constance, Justin Stiers, Michael G. Spigarelli, Robert M. Ward, Catherine M. T. Sherwin, Pharmacokinetics and Pharmacodynamics of Antibacterials, Antifungals, and Antivirals Used Most Frequently in Neonates and Infants, Clinical Pharmacokinetics, 2014, 53, 7, 581

    CrossRef

  12. 12
    Anaïs Vandendriessche, Karel Allegaert, Veerle Cossey, Gunnar Naulaers, Veroniek Saegeman, Anne Smits, Prospective validation of neonatal vancomycin dosing regimens is urgently needed, Current Therapeutic Research, 2014, 76, 51

    CrossRef

  13. 13
    Karel Allegaert, Tailored tools to improve pharmacotherapy in infants, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 8, 1069

    CrossRef

  14. 14
    Johannes N. van den Anker, The impact of therapeutic drug monitoring in neonatal clinical pharmacology, Clinical Biochemistry, 2014, 47, 9, 704

    CrossRef

  15. 15
    Wei Zhao, Valérie Biran, Evelyne Jacqz-Aigrain, Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates, Clinical Pharmacokinetics, 2013, 52, 12, 1127

    CrossRef